Virupaksha Organics Ltd. has emerged as a leader in the pharmaceutical industry, specializing in the manufacturing of Active Pharmaceutical Ingredients (APIs). Founded in 2003, the company has built a reputation for innovation, quality, and sustainability. Under the dynamic leadership of Mr. Chandra Mouliswar Reddy Gangavaram, Virupaksha has grown its operations significantly, with state-of-the-art manufacturing facilities in Telangana, India.
The company’s facilities in Kazipally and Pashamylaram are certified by international and national regulatory bodies, including ISO 9001, ISO 14001, ISO 45001, ISO 50001, and GMP standards, ensuring that Virupaksha meets the highest levels of quality and safety in its production processes. These certifications highlight the company’s commitment to environmental sustainability, occupational safety, and best industry practices.
Virupaksha Organics is committed to excellence, innovation, and customer satisfaction, with a focus on developing sustainable solutions for the pharmaceutical industry. The company’s products are trusted by major pharmaceutical firms globally, as it continues to make strides towards becoming a research-driven organization. With a forward-thinking management team and a clear vision for the future, Virupaksha Organics is poised for rapid growth and continues to play a key role in advancing global healthcare.
As part of its corporate social responsibility (CSR), Virupaksha has initiated numerous welfare programs aimed at uplifting local communities and supporting environmental conservation, reinforcing its reputation as a responsible corporate citizen.
With continuous advancements and strategic partnerships, Virupaksha Organics Ltd. is well-positioned to expand its global footprint and contribute to the evolving pharmaceutical landscape.
Other Latest News
- [CAGR of 6.2%] Paraben Market Size, Share, Latest Exclusive Report, 2031 EIN Presswire The global paraben market is projected to reach $164.8 million by 2031, growing at a CAGR of 6.2% from 2022 to 2031. WILMINGTON, DE, UNITED STATES, June 12, 2026 /EINPresswire.com/ -- According to the report published by Allied Market Research …
- Opening Bell: Can Bulls Extend Gains? Sensex Jumps 700 Pts, Nifty Above 23,300 News X 77 Stock Market Today | Opening Bell: If you were looking for a strong finish to the week on Dalal Street, Friday morning has provided just that. The Indian stock market has begun the last trading session of the week on a strong note as investors once …
- Insurers Aren’t the Villain of the Health Care System The Daily Economy In a post last week, I wrote about the progressive anti-monopoly movement’s increasing disconnect from reality. I wrote: [C]onsider the movement’s choice of targets. These include some industries with high profit margins, but also some with very low …
- Stock market today: Gift Nifty hints gap-up start; US-Iran peace deal to global markets rally - 7 stocks to buy Mint Stock market today, 12 June 2026: Indian benchmark indices Sensex and Nifty 50 are likely to open on a positive note on Friday, tracking strong gains across global markets after optimism grew over a possible peace agreement between the United States and …
- How did Prega News achieve an 85% market share in India’s pregnancy kit industry? Afaqs For just Rs 60, Indian women can determine whether their missed period warrants a visit to a gynaecologist or a trip to the toy store, thanks to Prega News’ home pregnancy detection kit. Not all pregnancies are celebrated, though; some women are also …
- Nasdaq surges, Dow gains 900 points on Iran deal hopes Proactive USA 4:20pm: Investors embrace risk again US stocks staged a powerful comeback on Thursday, with investors piling back into risk assets after President Donald Trump said he had cancelled planned military strikes against Iran and suggested a diplomatic agreement …
- ‘It was a holy and sacred experience to speak for them’ Matternews - Ohio Photo by Alery Robyn, courtesy Stacy Schwab When her name was called, her heart raced. She told the court that she did not know she would be asked to speak, so she didn’t come prepared. “I’m going to wing it,” she said. “Four foot eleven morphs into six …
- Why Pfizer Stock Popped Today The Motley Fool USA Pfizer (PFE +2.23%) shares gained 2.8% through 11:15 a.m. ET Thursday, and investors can thank the friendly bankers at RBC Capital Markets for that. This morning, RBC removed its sell rating from Pfizer stock, upgrading the shares from "underperform…
- Intel2Talent Canada Joins Forces with GlassRatner, Establishes Executive Search Practice in Montreal Shoreline Beacon Breadcrumb Trail Links PR Newswire GlassRatner Advisory & Capital Group, LLC CNW Brigitte Simard will lead the Montreal-based executive search practice, bringing established Quebec client relationships and expanded executive search capabilities to …
- SonoThera Raises $125M to Advance Gene Therapy Ventureburn SonoThera Inc. has secured a $125 million funding round to advance the development of a nonviral, ultrasound-mediated platform for gene therapy. This marked a major change for a significantly evolving industry, focusing on alternative delivery strategies …
- 5-Year Phase 2 Data Show TransCon® PTH Replicated Systemic Actions of Endogenous PTH in Adults with Hypoparathyroidism EIN Presswire – Multi-organ system and quality-of-life benefits sustained through five years of treatment – 82% response rate for the multi-component endpoint – 95% of patients completed five years of treatment COPENHAGEN, Denmark, June 11, 2026 (GLOBE NEWSWIRE) -- …
- Cosmos Health Signs LOI to Acquire Doc Pharma S.A., a European GMP Pharmaceutical Manufacturer, a Transformative Step Expected to Boost Assets, Profitability, Production Capacity, and Product Portfolio EIN Presswire Doc Pharma financial profile: approximately $24 million asset base, approximately $6.7 million in average annual revenue and approximately $3.2 million in average annual gross profit. Immediately accretive: expected to support margin expansion, …
- Stock markets close lower in volatile trade as escalating US-Iran tensions, FII outflow dent sentiment The Print Mumbai, Jun 11 (PTI) Benchmark stock indices Sensex and Nifty closed lower in a volatile trade on Thursday, as investors remained cautious amid rising tensions between the US and Iran. The 30-share BSE Sensex declined 150.63 points, or 0.20 per cent, to …
- Health Inflation Won't Stabilize Until Politicians Confront Monopoly Hospitals National Memo - New York Today’s inflation report is a wake-up call for wannabe-be health care reformers. It provides the perfect opening for injecting how to control hospital prices into this year’s political debate. The overall inflation rate ratcheted up 4.2% last month, driven …
- Buried Before Ivermectin: Meet Chlorine Dioxide Brownstone I always knew that corruption existed in every field. I assumed that when it came to Big Pharma, the same was true, but I thought of it as something abstract: an inflated contract here, an outrageously profitable deal there, an abusive markup somewhere …
- Novartis $12bn bet on Avidity well placed after mid-stage FSHD win Clinical Trials Arena Novartis’ $12bn Avidity Biosciences buyout is looking increasingly well positioned, as one of the latter company’s lead assets, delpacibart braxlosiran (del-brax), has posted a mid-stage win in the rare muscle wasting disease facioscapulohumeral muscular …
- Drug developers eye sport’s biggest stage as World Cup fever builds Pharmaceutical Technology As Mexico prepares to take on South Africa in the opening game of the 2026 FIFA World Cup today (11 June), a handful of pharmaceutical companies are set to contribute off the pitch in what could be the biggest sporting event in history. This year’s …
- <![CDATA[Pharma Pulse: A Surge In Drug Discontinuations and Unapproved Retatrutide Prescriptions]]> Pharmaceutical Commerce Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast bringing you the latest insights shaping patient access, regulatory policy, and healthcare innovation. I'm your host, and let's get into today's headlines. First up, a new annual drug …
- Novartis tightens bond with Orionis in up to $1.4B molecular glue deal BioSpace Novartis has decided to stick with long-time drug development partner Orionis Biosciences, continuing their work of advancing molecule glue assets across several disease areas and extending the recent trend of Big Pharmas striking deals for the modality. …
- [Economy Review] South Korea Growth Slips Amid Industrial Polarization Business Korea The South Korean economy in 2026 is passing through the threshold of a prolonged low-growth phase. As major domestic and foreign national and private research institutes successively downgrade or maintain their real Gross Domestic Product (GDP) growth …
- VGU Mega Job Fair 2026: 1,642 Candidates Selected by 100+ Recruiters, Highest Package Touches 44 LPA Detroit Star - Michigan VMPL Jaipur (Rajasthan) [India], June 11: In a major boost to youth employability and industry-academia collaboration, Vivekananda Global University (VGU), Jaipur successfully concluded its Mega Job Fair 2026 at the Rajasthan International Centre (RIC), …
- Medicus Pharma Initiates Groundbreaking PRECISION-E2 Phase 2a Study of Teverelix® in Endometriosis utilizing the Emirati Genome Program EIN Presswire PHILADELPHIA, June 11, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) (“Medicus” or the “Company”), a biotech/life sciences company focused on advancing the clinical development programs of novel and potentially disruptive therapeutic …
- Helus Pharma to Participate in the H.C. Wainwright 7th Annual Neuro Perspectives Conference EIN Presswire NEW YORK and TORONTO, June 11, 2026 (GLOBE NEWSWIRE) -- Helus PharmaTM (Nasdaq: HELP) (Cboe CA: HELP), a clinical-stage pharmaceutical company committed to helping minds heal by developing novel serotonergic agonists (“NSAs”), today announced that Amir …
- Sun Pharma sets record, payment dates for FY26 final dividend Business Today Sun Pharmaceutical Industries Ltd, the country's largest pharma company, on Thursday announced record and payment dates for the final dividend payment of Rs 5 per share for the financial year 2025-26 (FY26). It has fixed July 7, 2026, as the record …
- Global Next Generation Sequencing Services Market Size/Share Worth USD 56.1 Billion by 2035 at a 23.5% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, SWOT Analysis) EIN Presswire Austin, TX, USA, June 11, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “Next Generation Sequencing Services Market Size, Trends and Insights By Service Type (Human Genome Sequencing Services, Microbial Genome- …
- I'm a Neuroscientist—6 Daily Habits to Prioritise Over Supplements for Brain Function and Longevity Marie Claire UK Follow us Add us as a preferred source on Google Newsletter Subscribe to our newsletter Hands up if you're supplemented out? Yep, us too. Between A-listers waxing lyrical about their 35 supplements-a-day habits (Kim Kardashian, we're looking at you …
- [2026] Povidone Iodine Market Growing at a CAGR of 4.7% to 2031, Says AMR EIN Presswire The global povidone iodine market is projected to reach $242.2 million by 2031, growing at a CAGR of 4.7% from 2022 to 2031 WILMINGTON, DE, UNITED STATES, June 11, 2026 /EINPresswire.com/ -- Allied Market Research has published a report on the …
- States look at forcing Congress to fix the debt Deseret News - Utah As Congress has failed to deal with the country’s growing debt, Florida Gov. Ron DeSantis said it’s up to the states to force Congress to balance the budget. At a recent conference in Washington, D.C., a bipartisan group of researchers and elected …
- Opening Bell: Sensex, Nifty Open Lower; IT Stocks Lead Declines News X 66 Stock Market Today, June 11, 2026: Dalal Street opened on a weak note on Thursday. On the back of selling in IT stocks, the benchmark indices turned red, which wiped off some of the gains of a few banking & telecom stocks. While the BSE Sensex …
- Eli Lilly Wins Court Order in Fraud Allegations Against Florida, TN Pharmacy Groups Insurance Journal Eli Lilly, one of the world’s largest pharmaceutical makers, has won a federal court order against leaders of a Tennessee church and Florida and Tennessee-based pharmacy groups, after the drugmaker said the participants had crafted a years-long scheme that …
- Life expectancy lower with COPD regardless of smoking status Healio News Add topic to email alerts Subscribe We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio Key takeaways: The mean number of years of life lost in those …
- Lunch Wrap: ASX caught between surging oil and falling gold prices Stockhead ASX hit by different forces on Thursday. Pic: Getty Images Oil spikes as ASX slips Gold miners cop another hit Megaport opens $309 million raise The S&P/ASX 200 was down 0.60% by lunchtime in Sydney on Thursday, as investors spent the morning …
- AstraZeneca’s ‘extensive’ obesity drug push; $125M for ultrasound-aided genetic medicine BioPharma Dive Today, a brief rundown of news involving AstraZeneca and SonoThera, as well as updates from Bausch + Lomb, Cartesian Therapeutics and Eli Lilly and that you may have missed. AstraZeneca will move an experimental weight pill into an “extensive” Phase 3 …
- World News | Jaishankar Holds Talks with Bulgarian PM, Foreign Minister to Deepen Strategic Partnership Latestly Sofia [Bulgaria], June 10 (ANI): External Affairs Minister S Jaishankar on Wednesday held high-level talks with Bulgarian leaders, including Prime Minister Rumen Radev and Foreign Minister Velislava Petrova-Chamova, focusing on expanding bilateral …
- <![CDATA[Pharmaceutical Executive Daily: Parabilis Medicines Prices Record-Breaking $670 Million IPO]]> Pharmaceutical Executive Welcome to Pharmaceutical Executive Daily, your quick briefing on the top news shaping the pharmaceutical and life sciences industry. In today's Pharmaceutical Executive Daily, Parabilis Medicines prices a record-breaking $670 million IPO, Swedish …
- The CEO innovating in Ireland’s ‘controlled and cautious’ medical cannabis space Silicon Republic Dunbar Pharma’s Leah Fletcher discusses Ireland’s potential in the cannabinoid therapy landscape and how breaking tradition is a critical step towards advancement. Leah Fletcher is the co-founder and CEO of Irish biopharmaceutical Dunbar Pharma, which …
- Column: Irish benefit from AbbVie’s pot o’ gold Chicago Tribune - Illinois DUBLIN, Ireland — The broad reach of Lake County’s elite corporations is one with international influence. For instance, AbbVie is one of the largest tax contributors to the Irish economy. For those in the Emerald Isle, that’s good news. But, Irish …
- Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons EIN Presswire Company announcement – No. 24 / 2026 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons Copenhagen, Denmark, June 10, 2026 – Zealand Pharma …
- Eli Lilly continues dealmaking roll with $1bn AlzeCure agreement Pharmaceutical Technology Eli Lilly has inked a licensing deal worth up to $1bn with Swedish Alzheimer’s-focused biotech, AlzeCure – marking a continuation of the pharma giant’s 2026 dealmaking spree. Lilly will secure the rights to AlzeCure’s therapeutic candidate, ACD680, in …
- Nxera Taps OpenFold's AI Ecosystem To Advance GPCR Drug Discovery RTTNews Nxera Pharma Co., Ltd. (SOLTF) has joined OpenFold, a global open-source AI research consortium that develops advanced structural prediction tools for biology and drug discovery. The group includes leading pharmaceutical companies such as Bristol Myers …
- ECLGS 5.0 guarantees cross 1 lakh mark, covers over Rs 48,000 Cr in credit protection United News of India More News 10 Jun 2026 | 6:35 PMHyderabad, June 10 (UNI) The Singareni Collieries Company Limited (SCCL) has received approval for the refund of nearly Rs 40 crore, including accrued interest, from the Coal Controller Organisation (CCO) following the …
- Lilly tees off with Novo at ADA, GSK’s $10.6B deal, FDA reform continues in Makary’s absence BioSpace > Listen on Spotify > Listen on Apple Products > Listen on Amazon Music > Listen on iHeart Everything came up roses for Eli Lilly at the American Diabetes Association’s Scientific Sessions in New Orleans this past weekend, as the pharma boasted …
- Sanofi’s $11.6bn Bioverativ purchase looks hit-and miss after phase 3 rare diseases drug runs into trouble European Biotechnology When Sanofi coughed up $11.6bn for rare diseases pharma Bioverativ in 2018, many commentators said the French firm had overpaid. It’s true that the deal has led to a rare disease blockbuster for Sanofi, but it remains to be seen whether the sales will …
- World News | Piyush Goyal Meets Ernst & Young CEO, Discusses India's Role in Global Supply Chains Latestly New Delhi [India], June 10 (ANI): Union Minister Piyush Goyal held a meeting with Janet Truncale, Global Chair and CEO of Ernst & Young (EY), to discuss India's growing role in global supply chains and the expanding opportunities in Global …
- Billionaire Stanley Druckenmiller Likes This Small-Cap Pharma Stock in 2026 Yahoo Finance We just covered the 10 Best Non-AI Stocks to Buy According to Billionaire Stanley Druckenmiller. NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) ranks #5 (see 5 Best Non-AI Stocks to Buy According to Billionaire Stanley Druckenmiller). Druckenmiller’s Stake …
- This Week’s Biopharma News: Big Moves in Bispecifics The Medicine Maker Ivonescimab beats PD-1 plus chemo in first-line squamous NSCLC Akeso’s ivonescimab, a first-in-class PD-1/VEGF bispecific antibody, has improved overall survival versus PD-1 plus chemotherapy in patients with advanced squamous non-small cell lung …
- Business News | Himachal Government Clears 42 Investment Proposals Worth Rs 5,877 Crore; over 13,000 Employment Opportunities Expected Latestly Shimla [Himachal], June 9 (ANI): The Himachal Pradesh Government has approved investment proposals of Rs. 5877.01 crore that can generate over 13,000 employment opportunities in the state. The decision was taken in the 32nd Meeting of the State Single …
- <![CDATA[Deepening Ties: Why China is Becoming Big Pharma's Most Essential R&D Partner]]> Pharmaceutical Executive The pace and scale of the pharma industry’s turn toward China in early 2026 is difficult to overstate, with more than $43 billion in licensing commitments in just five months. What is currently unfolding can be described as a structural realignment of …
- <![CDATA[Pharma Funding Roundup: City Therapeutics Closes $99.5 Million Series B, Eloxx Pharmaceuticals Announces Pricing of $66 Million Public Offering ]]> Pharmaceutical Executive Two RNA-focused biotechs secured fresh capital this week, as City Therapeutics closed a $99.5 million Series B to advance its RNAi pipeline and Eloxx Pharmaceuticals raised $66 million in a public offering tied to its Nasdaq uplisting. City Therapeutics …
- Chinese pharma contractor under watch: Pentagon names WuXi AppTec on military list The Print WuXi AppTec Co. will face fresh questions about its growth prospects after the Pentagon named the major pharmaceutical contractor on a list of firms associated with the Chinese military, a move that could also complicate research being done by American …